Article

Vitamin D Helps Fracture Prevention in Older Patients

High-dose vitamin D supplementation was somewhat favorable in preventing hip fracture and any nonvertebral fracture in persons aged 65 years and older in a Swiss study that appeared recently in the New England Journal of Medicine.

High-dose vitamin D supplementation was somewhat favorable in preventing hip fracture and any nonvertebral fracture in persons aged 65 years and older in a Swiss study that appeared recently in the New England Journal of Medicine. Researchers pooled participant-level data from 11 double-blind, randomized, controlled trials of oral vitamin D supplementation, with and without calcium, compared with placebo or calcium alone. The primary goal was to compare data from quartiles of actual intake of vitamin D in the treatment groups of all trials with data from the control groups, including each patient's adherence to the treatment regimen and supplement use outside the study protocol.

There was a nonsignificant 10% reduction in the risk of hip fracture and a 7% reduction in the risk of nonvertebral fracture in patients who were randomly assigned to receive vitamin D compared with those assigned to control groups. By quartiles of actual intake, reduction in fracture risk was shown only at the highest intake level (median, 800 IU/d; range, 792 to 2000 IU/d), with a 30% reduction in hip fracture risk and a 14% reduction in the risk of any nonvertebral fracture. Benefits at the highest level of vitamin D intake were somewhat consistent across age-group, type of dwelling, baseline 25-hydroxyvitamin D level, and additional calcium intake subgroups.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2025 MJH Life Sciences

All rights reserved.